Multidisciplinary cancer care depends on precision. A surgeon mapping an operative plan, a medical oncologist preparing systemic therapy, a radiation oncologist calibrating fields, and a palliative team guiding expectations all need access to the same, current picture of the patient. When that picture is incomplete or delayed, decisions stall, appropriate treatment is not delivered, and patients shoulder the weight of uncertainty at a time when clarity is most needed. Electronic health records have improved access to information, but they often fall short in presenting a unified, validated view of the patient’s journey. The institutional cancer registry, long regarded primarily as a retrospective reporting tool, can address this gap. When hospitals treat their oncology registry data as a coordination layer, it becomes a central resource that accelerates treatment planning, reduces the risk of handoff errors, and provides leaders with a clearer line of sight into quality performance.
Where coordination falters
Hospitals have made significant progress in exchanging clinical data across systems. The Office of the National Coordinator (ONC) reports that roughly 70 percent of U.S. nonfederal acute care hospitals now participate in all four domains of interoperable exchange: sending, receiving, finding, and integrating patient information. Yet consistent, seamless integration into workflows remains elusive. In practice, clinicians often receive fragments rather than a complete picture.
The impact of those gaps is well documented. The Joint Commission has found that nearly two-thirds of communication errors occur at handoffs. Controlled studies demonstrate that standardized handoff interventions can reduce medical errors and adverse events significantly, underscoring how much is at stake. In oncology, the consequences are magnified. Multiple specialties must align around complex, time-sensitive decisions. When communication falters, delays in treatment initiation, unnecessary duplication of diagnostics, and patient frustration often follow.
The overlooked potential of oncology registry data
Cancer registries already house much of the information required for high-quality coordination: confirmed diagnoses, stage at presentation, biomarker data, dates of surgery or systemic therapy, and treatment intent. These fields are abstracted and validated, giving them a level of reliability that scattered EHR fields often lack.
The National Cancer Database continues to serve as the primary benchmarking and analytic repository for Commission on Cancer–accredited programs. Beginning in 2020, the Rapid Cancer Reporting System (RCRS) became the sole data submission portal, replacing both the previous Rapid Quality Reporting System and the NCDB’s annual Call for Data. Today, cancer programs submit new and updated cases continuously through RCRS, which supports both real-time and historical quality measurement.
This shift means the registry is no longer a lagging indicator. For leadership teams, it is a pathway to actionable intelligence that can support both clinical decision-making and strategic planning.
Building a registry-powered coordination model
For executives seeking to strengthen multidisciplinary care, four pillars can guide the transition from retrospective reporting to operational utility.
1. Timely and curated updates
Move from annual abstraction cycles toward more frequent updates that mirror clinical rhythm. Programs submitting regularly to RCRS can see performance on key measures within months rather than years. Prioritize fields that directly influence decisions, such as pathology confirmation dates, biomarker results, and treatment start dates.
2. Clinician-facing summaries
Registry data must be presented in a form that supports clinical action. Tumor board packets that provide a one-page synopsis—diagnosis, stage, molecular markers, treatment to date, and key questions—are far more valuable than raw extracts. With consistent formatting, teams come to meetings with the same validated information, reducing time spent reconciling conflicting reports.
3. Standardized handoffs
Define the minimum data set required for every transition between surgery, medical oncology, radiation oncology, and palliative care. Incorporate those fields into a structured handoff protocol and assign clear accountability for updates. Evidence shows that structured communication protocols reduce the frequency of medical errors, making this a high-value intervention.
4. Continuous measurement and feedback
Executives should expect metrics that provide a clear operational signal. Time from diagnosis to first treatment, time from tumor board decision to order entry, and adherence to specific Commission on Cancer measures provide actionable insights. Handoff clarification rates—how often teams must seek missing information—are another useful indicator of coordination quality. With RCRS, programs can benchmark these metrics against peer institutions, creating accountability and focus.
Evidence of impact
The value of complete, timely data in multidisciplinary review is well supported. Studies of tumor boards have consistently shown that management recommendations change for a significant portion of patients when full diagnostic and staging data are available. Molecular tumor boards, in particular, have demonstrated that curated, comprehensive data lead to actionable therapy recommendations and measurable improvements in selected patient cohorts.
From an operational perspective, early adopters of structured handoff programs have reported reductions in error rates and improved clinician satisfaction. These experiences reinforce the principle that when information is curated and shared consistently, both safety and efficiency improve.
Moving from concept to practice
For hospital leaders, the challenge is translating these principles into operational change. A pragmatic first step is to identify a single high-volume disease site and pilot registry-driven coordination. Within a 90-day window, programs can:
- Select three registry fields that directly reduce decision latency.
- Generate clinician-ready tumor board packets using those fields.
- Implement a standardized handoff template across two service lines.
- Track three core metrics: decision-to-order interval, first-treatment timeliness, and handoff clarification rate.
This contained approach produces early results that can be reviewed at the executive level and scaled to additional service lines.
The patient perspective
For patients, the benefits of registry-enabled coordination are experienced in subtle but profound ways. Instead of hearing conflicting recommendations from different specialists, they receive a consistent plan. Instead of waiting weeks between decisions and treatment initiation, they move forward with greater speed. And instead of feeling like the messenger between siloed teams, they can trust that their clinicians are working from the same information.
Positioning for the future
The pressure on hospitals to demonstrate quality and efficiency in oncology will only grow, as accreditation standards evolve and payers increase their focus on outcomes. Investing in the registry as a coordination tool positions programs to meet these demands while improving daily operations. It turns a compliance obligation into a strategic asset.
Leveraging RegiHealth to maximize the value of oncology registry data
The true potential of registry data is realized when it directly supports the workflows and decisions of multidisciplinary teams. Hospitals that treat the registry as a static reporting requirement risk missing opportunities to reduce delays, clarify handoffs, and track meaningful operational metrics.
RegiHealth was developed by Registry Partners to help hospitals bridge that gap. The program positions registry data as a strategic resource, giving leaders the insights they need to monitor performance, identify bottlenecks, and guide improvement initiatives across oncology programs. By connecting data to decision-making, RegiHealth reinforces the themes explored in this article: timely information, coordinated care, and actionable measurement.
For hospital leaders looking to move beyond compliance and fully operationalize their registry data, RegiHealth offers guidance and support to translate data into insights that matter for patients, clinicians, and the organization as a whole.
